Successful trial of groundbreaking device, now approved by Nice, uses algorithm to determine amount of insulin needed
More than 100,000 people with type 1 diabetes in England are to be offered an artificial pancreas, which experts believe could become the “holy grail” for managing the disease.
The groundbreaking device uses an algorithm to determine the amount of insulin that should be administered and reads blood sugar levels to keep them steady.
Successful trial of groundbreaking device, now approved by Nice, uses algorithm to determine amount of insulin neededMore than 100,000 people with type 1 diabetes in England are to be offered an artificial pancreas, which experts believe could become the “holy grail” for managing the disease.The groundbreaking device uses an algorithm to determine the amount of insulin that should be administered and reads blood sugar levels to keep them steady. Continue reading…
